XRAY
DENTSPLY SIRONA Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-44/100
Last price
8.48
▼ 0.08 (0.93%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
8.60
Prev close
8.56
Day high
8.69
Day low
8.47
Volume
4.72M
Market cap
$1.70B
P/E (TTM)
—
52W range
8.44 – 14.76
Day trading desk
Gap from prior close
+0.47%
Prior close 8.56
VWAP
8.54
-0.65% from price
Relative volume
1.59×
Unusually busy
Session range
20.26%
7.80 – 9.38
Position in range
43%
Mid range
ATR (14D)
0.36
4.20% of price
Prior day high
8.70
PDH
Prior day low
8.44
PDL
Bid / ask spread
—
Quote not published
Session volume
7.54M
Avg 4.74M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-5.12%
-7.1%
1M
-25.13%
-26.3%
3M
-27.67%
-32.2%
6M
-26.04%
-44.2%
YTD
-25.46%
-39.7%
1Y
-35.41%
-51.8%
3Y
-75.06%
-157.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on XRAY open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.29M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 10, 26 | FORTSON JOHN C Chief Financial Officer |
STOCK | 24.01K | $0 | Direct |
| Jun 15, 26 | HOSEIN CLYDE R Director |
BUY | 6.50K | $64.90K | Direct |
| Jun 15, 26 | GLADDEN BRIAN T Director |
BUY | 9.98K | $100.00K | Direct |
| Jun 12, 26 | MAZELSKY JONATHAN JAY Director |
STOCK | 10.00K | $101.40K | Direct |
| Jun 12, 26 | MAZELSKY JONATHAN JAY Director |
BUY | 10.00K | $101.40K | Direct |
| Jun 12, 26 | MCKEON BRIAN P Director |
BUY | 10.00K | $101.20K | Indirect |
| Jun 11, 26 | BARBER MICHAEL J Director |
BUY | 15.18K | $150.00K | Direct |
| Jun 11, 26 | HOLDEN BETSY D Director |
BUY | 10.09K | $99.69K | Direct |
| Jun 3, 26 | MAZELSKY JONATHAN JAY Director |
STOCK | 22.82K | $0 | Direct |
| Jun 3, 26 | VERGIS JANET S Director |
STOCK | 22.82K | $0 | Direct |
| Jun 3, 26 | VARON LESLIE F. Director |
STOCK | 22.82K | $0 | Direct |
| Jun 3, 26 | HOSEIN CLYDE R Director |
STOCK | 22.82K | $0 | Direct |
| Jun 3, 26 | BARBER MICHAEL J Director |
STOCK | 22.82K | $0 | Direct |
| Jun 3, 26 | LUCIER GREGORY T Director |
STOCK | 38.38K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CAMPION SIMON D |
Chief Executive Officer | 272.40K | Stock Award(Grant) |
COLEMAN GLENN G |
Chief Financial Officer | 89.77K | Stock Award(Grant) |
FRANK ANDREAS G |
Officer | 119.86K | Stock Award(Grant) |
HOLDEN BETSY D |
Director | 87.53K | Purchase |
HOSEIN CLYDE R |
Director | 70.58K | Purchase |
JOHNSON ROBERT ANTHONY |
Officer | 161.82K | Stock Award(Grant) |
LUCIER GREGORY T |
Director | 149.28K | Stock Award(Grant) |
ROSENZWEIG RICHARD C |
General Counsel | 85.18K | Stock Award(Grant) |
SCAVILLA DANIEL T |
Chief Executive Officer | 161.84K | Stock Award(Grant) |
VARON LESLIE F. |
Director | 80.36K | Stock Award(Grant) |
Fundamentals
Market cap$1.70B
Enterprise value$3.79B
Revenue (TTM)$3.64B
Gross profit$1.80B
EBITDA$526.00M
Net income$-546.00M
EPS (TTM)$-2.72
Free cash flow$141.62M
Total cash$239.00M
Total debt$2.33B
Book value / share$6.58
Shares outstanding199.35M
Float187.87M
Short % of float13.76%
Dividend yield0.00%
Beta (5Y)0.88
Valuation & profitability ratios
Trailing P/E—
Forward P/E5.69
PEG ratio0.55
Price / sales—
Price / book1.29
EV / revenue1.04
EV / EBITDA7.20
Gross margin49.52%
Operating margin9.24%
Profit margin-14.99%
Return on equity-33.03%
Return on assets1.96%
Debt / equity172.24
Current ratio1.63
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $3.68B | $3.79B | $3.96B | $3.92B | -3.0% |
| Operating revenue | $3.68B | $3.79B | $3.96B | $3.92B | -3.0% |
| Cost of revenue | $1.84B | $1.83B | $1.88B | $1.79B | +0.3% |
| Gross profit | $1.84B | $1.96B | $2.09B | $2.13B | -6.0% |
| Research & development | $150.00M | $165.00M | $184.00M | $174.00M | -9.1% |
| Selling, general & admin | $1.44B | $1.60B | $1.61B | $1.59B | -10.4% |
| Total operating expense | $1.59B | $1.77B | $1.80B | $1.76B | -10.3% |
| Operating income | $252.00M | $188.00M | $289.00M | $364.00M | +34.0% |
| Net interest income | -$88.00M | -$69.00M | -$81.00M | -$65.00M | -27.5% |
| Pre-tax income | -$486.00M | -$936.00M | -$175.00M | -$1.05B | +48.1% |
| Tax provision | $112.00M | -$26.00M | -$43.00M | -$105.00M | +530.8% |
| Net income | -$598.00M | -$910.00M | -$132.00M | -$950.00M | +34.3% |
| Net income to common | -$598.00M | -$910.00M | -$132.00M | -$950.00M | +34.3% |
| Basic EPS | -3.00 | -4.48 | -0.62 | -4.41 | +33.0% |
| Diluted EPS | -3.00 | -4.48 | -0.62 | -4.41 | +33.0% |
| EBIT | -$398.00M | -$867.00M | -$94.00M | -$990.00M | +54.1% |
| EBITDA | -$46.00M | -$518.00M | $249.00M | -$662.00M | +91.1% |
| Basic shares | 199.40M | 203.20M | 212.00M | 215.50M | -1.9% |
| Diluted shares | 199.40M | 203.20M | 212.00M | 215.50M | -1.9% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $326.00M | $272.00M | $334.00M | $365.00M | +19.9% |
| Cash & short-term investments | $326.00M | $272.00M | $334.00M | $365.00M | +19.9% |
| Accounts receivable | $688.00M | $556.00M | $695.00M | $632.00M | +23.7% |
| Inventory | $642.00M | $564.00M | $624.00M | $627.00M | +13.8% |
| Total current assets | $2.02B | $1.75B | $1.97B | $1.89B | +15.9% |
| Property, plant & equipment | $1.00B | $902.00M | $978.00M | $961.00M | +10.9% |
| Goodwill & intangibles | $2.12B | $2.80B | $4.14B | $4.59B | -24.3% |
| Total assets | $5.43B | $5.75B | $7.37B | $7.64B | -5.6% |
| Total current liabilities | $1.34B | $1.59B | $1.43B | $1.17B | -15.5% |
| Current debt | $313.00M | $549.00M | $322.00M | $118.00M | -43.0% |
| Long-term debt | $2.02B | $1.59B | $1.80B | $1.83B | +27.0% |
| Total debt | $2.47B | $2.27B | $2.30B | $2.15B | +8.6% |
| Total liabilities | $4.09B | $3.81B | $4.08B | $3.83B | +7.3% |
| Retained earnings | -$1.56B | -$835.00M | $205.00M | $456.00M | -87.3% |
| Shareholder equity | $1.34B | $1.94B | $3.29B | $3.81B | -31.1% |
| Working capital | $680.00M | $157.00M | $548.00M | $723.00M | +333.1% |
| Net tangible assets | -$783.00M | -$862.00M | -$850.00M | -$780.00M | +9.2% |
| Shares issued | 264.50M | 264.50M | 264.50M | 264.60M | 0.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$598.00M | -$910.00M | -$132.00M | -$950.00M | +34.3% |
| Depreciation & amortisation | $352.00M | $349.00M | $343.00M | $328.00M | +0.9% |
| Stock-based compensation | $33.00M | $39.00M | $46.00M | $59.00M | -15.4% |
| Change in working capital | -$222.00M | $95.00M | -$56.00M | -$78.00M | -333.7% |
| Operating cash flow | $235.00M | $461.00M | $377.00M | $517.00M | -49.0% |
| Capital expenditure | -$131.00M | -$180.00M | -$149.00M | -$149.00M | +27.2% |
| Investing cash flow | -$132.00M | -$197.00M | -$89.00M | -$138.00M | +33.0% |
| Share buybacks | $0 | -$250.00M | -$300.00M | -$150.00M | +100.0% |
| Dividends paid | -$128.00M | -$126.00M | -$116.00M | -$104.00M | -1.6% |
| Financing cash flow | -$80.00M | -$302.00M | -$307.00M | -$329.00M | +73.5% |
| Free cash flow | $104.00M | $281.00M | $228.00M | $368.00M | -63.0% |
| End cash position | $326.00M | $272.00M | $334.00M | $365.00M | +19.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $898.00M | $880.00M | $961.00M | $904.00M | $936.00M | +2.0% |
| Operating revenue | $898.00M | $880.00M | $961.00M | $904.00M | $936.00M | +2.0% |
| Cost of revenue | $405.00M | $453.00M | $518.00M | $463.00M | $446.00M | -10.6% |
| Gross profit | $493.00M | $427.00M | $443.00M | $441.00M | $490.00M | +15.5% |
| Research & development | $45.00M | $44.00M | $40.00M | $37.00M | $37.00M | +2.3% |
| Selling, general & admin | $365.00M | $353.00M | $378.00M | $358.00M | $344.00M | +3.4% |
| Total operating expense | $410.00M | $397.00M | $418.00M | $395.00M | $381.00M | +3.3% |
| Operating income | $83.00M | $30.00M | $25.00M | $46.00M | $109.00M | +176.7% |
| Net interest income | -$22.00M | -$24.00M | -$22.00M | -$23.00M | -$24.00M | +8.3% |
| Pre-tax income | $72.00M | -$42.00M | -$147.00M | -$230.00M | -$153.00M | +271.4% |
| Tax provision | $36.00M | -$32.00M | -$2.00M | $198.00M | -$109.00M | +212.5% |
| Net income | $37.00M | -$10.00M | -$146.00M | -$427.00M | -$45.00M | +470.0% |
| Net income to common | $37.00M | -$10.00M | -$146.00M | -$427.00M | -$45.00M | +470.0% |
| Basic EPS | 0.18 | -0.05 | -0.74 | -2.14 | -0.22 | +460.0% |
| Diluted EPS | 0.18 | -0.05 | -0.74 | -2.14 | -0.22 | +460.0% |
| EBIT | $94.00M | -$18.00M | -$125.00M | -$207.00M | -$129.00M | +622.2% |
| EBITDA | $179.00M | $61.00M | -$32.00M | -$115.00M | -$41.00M | +193.4% |
| Basic shares | 199.70M | 199.90M | 199.60M | 199.50M | 199.30M | -0.1% |
| Diluted shares | 200.50M | 199.90M | 199.60M | 199.50M | 199.30M | +0.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $239.00M | $190.00M | $326.00M | $363.00M | $359.00M | +25.8% |
| Cash & short-term investments | $239.00M | $190.00M | $326.00M | $363.00M | $359.00M | +25.8% |
| Accounts receivable | $620.00M | $622.00M | $688.00M | $654.00M | $646.00M | -0.3% |
| Inventory | $665.00M | $659.00M | $642.00M | $686.00M | $675.00M | +0.9% |
| Total current assets | $1.93B | $1.84B | $2.02B | $2.07B | $1.97B | +4.5% |
| Property, plant & equipment | $974.00M | $997.00M | $1.00B | $972.00M | $979.00M | -2.3% |
| Goodwill & intangibles | $2.01B | $2.07B | $2.12B | $2.33B | $2.66B | -2.8% |
| Total assets | $5.20B | $5.23B | $5.43B | $5.65B | $6.07B | -0.5% |
| Total current liabilities | $1.19B | $1.21B | $1.34B | $1.41B | $1.17B | -1.8% |
| Current debt | $228.00M | $230.00M | $313.00M | $378.00M | $184.00M | -0.9% |
| Long-term debt | $2.00B | $2.01B | $2.02B | $2.02B | $2.22B | -0.5% |
| Total debt | $2.31B | $2.33B | $2.47B | $2.48B | $2.49B | -0.8% |
| Total liabilities | $3.85B | $3.91B | $4.09B | $4.17B | $4.11B | -1.5% |
| Retained earnings | -$1.54B | -$1.57B | -$1.56B | -$1.39B | -$925.00M | +2.4% |
| Shareholder equity | $1.35B | $1.32B | $1.34B | $1.48B | $1.96B | +2.5% |
| Working capital | $743.00M | $638.00M | $680.00M | $667.00M | $800.00M | +16.5% |
| Net tangible assets | -$657.00M | -$748.00M | -$783.00M | -$857.00M | -$701.00M | +12.2% |
| Shares issued | 199.20M | 264.50M | 264.50M | 264.48M | 264.50M | -24.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $36.00M | -$10.00M | -$145.00M | -$428.00M | -$44.00M | +460.0% |
| Depreciation & amortisation | $85.00M | $79.00M | $93.00M | $92.00M | $88.00M | +7.6% |
| Stock-based compensation | $9.00M | $8.00M | $8.00M | $6.00M | $9.00M | +12.5% |
| Change in working capital | -$51.00M | $44.00M | $29.00M | -$27.00M | -$113.00M | -215.9% |
| Operating cash flow | $99.00M | $40.00M | $101.00M | $79.00M | $48.00M | +147.5% |
| Capital expenditure | -$44.00M | -$52.00M | -$41.00M | -$39.00M | -$32.00M | +15.4% |
| Investing cash flow | -$39.00M | -$53.00M | -$45.00M | -$36.00M | -$34.00M | +26.4% |
| Share buybacks | — | — | $0 | $0 | — | — |
| Dividends paid | $0 | -$32.00M | -$32.00M | -$32.00M | -$32.00M | +100.0% |
| Financing cash flow | -$11.00M | -$119.00M | -$99.00M | -$36.00M | -$68.00M | +90.8% |
| Free cash flow | $55.00M | -$12.00M | $60.00M | $40.00M | $16.00M | +558.3% |
| End cash position | $239.00M | $190.00M | $326.00M | $363.00M | $359.00M | +25.8% |
Options analytics
Put / call volume
0.43
Call-heavy session
Put / call open interest
0.28
Positioning, not flow
Max pain
20.00
+134.7% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
109
Contracts, this expiry
Put volume
47
Contracts, this expiry
Heaviest call OI
20.00
81 contracts
Heaviest put OI
15.00
30 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.35 | 0.52 | +50.1% |
| Mar 2026 | 0.27 | 0.27 | -1.6% |
| Dec 2025 | 0.29 | 0.27 | -6.0% |
| Sep 2025 | 0.45 | 0.37 | -17.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.31 | 16 | $862.86M | -4.6% |
| Next quarter | 0.46 | 16 | $936.20M | -2.6% |
| Current year | 1.50 | 17 | $3.57B | -2.9% |
| Next year | 1.50 | 17 | $3.62B | +1.4% |
Analyst targets & ownership
Mean target$13.40
High target$17.00
Low target$9.00
Implied upside58.02%
Analyst count15
ConsensusHOLD
Strong buy / Buy2 / 2
Hold12
Sell / Strong sell0 / 1
Held by insiders0.65%
Held by institutions117.65%
Institutions holding493
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
9.03
-6.11% from price
SMA 20
9.53
-10.63% from price
SMA 50
10.96
-22.23% from price
SMA 100
11.03
-23.11% from price
SMA 200
11.58
-26.43% from price
EMA 12
9.09
-6.72% from price
EMA 26
9.74
-12.96% from price
EMA 50
10.41
-18.54% from price
RSI (14)
26.1
Oversold
MACD (12,26,9)
-0.65
Hist -0.05
ATR (14)
0.36
4.18% of price
Realised vol 30D
41.6%
Annualised
Bollinger upper
10.86
20, 2σ
Bollinger lower
8.20
20, 2σ
50 / 200 cross
Death
10.96 vs 11.58
Trend bias
Below 200
-26.43%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.19
More volatile than market
Correlation to SPY
0.33
Loosely linked
Realised vol 30D
41.6%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-42.0%
Peak to trough
Max drawdown 5Y
-85.6%
Peak to trough
ATR 14
0.36
4.18% of price
Beta (reported)
0.88
5Y monthly, from filing
Short interest
Shares short
24.59M
Prior 19.68M
Change vs prior
+24.9%
Shorts adding
% of float
13.76%
Elevated
% of shares out
12.33%
Against total outstanding
Days to cover
7.0
Crowded exit
Float
187.87M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 17, 26 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
| Aug 24, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| Jul 29, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Jul 9, 26 | BMO Capital | INITIATED | — | Market Perform |
| Jun 4, 26 | Barclays | MAINTAINED | Underweight | Underweight |
| May 7, 26 | UBS | MAINTAINED | Buy | Buy |
| May 6, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Apr 15, 26 | Citigroup | INITIATED | — | Sell |
| Mar 2, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Mar 2, 26 | Barrington Research | MAINTAINED | Outperform | Outperform |
| Feb 27, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Feb 27, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
Dividends & splits
Forward rate$0.00 / yr
Forward yield0.00%
5-year avg yield1.82%
Payout ratio29.56%
Ex-dividend dateDec 26, 2025
Next pay dateJan 9, 2026
Last split2:1
Split dateJul 18, 2006
SEC filings
Corporate Changes & Voting Matters
8-K/A · 2026-08-07
Periodic Financial Reports
10-Q · 2026-08-06
Offering Registrations
S-8 · 2026-06-26
Corporate Changes & Voting Matters
8-K · 2026-06-11
Corporate Changes & Voting Matters
8-K · 2026-06-04
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Periodic Financial Reports
10-Q · 2026-05-05
Proxy Statements
DEF 14A · 2026-04-23
Headlines
Dentsply Sirona Expands Distribution Collaboration With Midwest Dental
MT Newswires · 15h ago
Dentsply Sirona Continues North American Commercial Expansion with Midwest Dental Agreement
GlobeNewswire · 16h ago
Dental Implants and Prosthetics Market Forecasts Growth from $12.79B (2026) to $17.67B by 2031, Profiling Institut Straumann, Envista, Dentsply Sirona & Henry Schein
GlobeNewswire · 6d ago
Dental Equipment Market Forecasts Growth from $8.31B (2026) to $11.48B by 2031, Profiling Envista, Carestream Dental, Nakanishi & Dentsply Sirona
GlobeNewswire · 7d ago
Dental Consumables Market Forecasts Growth from $37.0B (2026) to $54.0B by 2031, Profiling Institut Straumann, Envista, Dentsply Sirona & 3M
GlobeNewswire · 7d ago
3 Stocks Under $10 Walking a Fine Line
StockStory · 9d ago
Q2 Rundown: Dentsply Sirona (NASDAQ:XRAY) Vs Other Dental Equipment & Technology Stocks
StockStory · 11d ago
1 Value Stock with Impressive Fundamentals and 2 Facing Headwinds
StockStory · 14d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.